Recombinant SARS-CoV-2 Nucleocapsid Protein

Referência 230-01104-100

Tamanho : 100ug

Marca : RayBiotech

Contactar o distribuidor local :


Telefone : +1 850 650 7790

Recombinant SARS-CoV-2 Nucleocapsid Protein

Recombinant SARS-CoV-2 Nucleocapsid Protein derived from E.coli
Contact Us for Bulk Request

Product Description

Specifications

Size100 µg, 500 µg, 1000 µg
SpeciesSARS-CoV-2
Accession Number
QHD43423
Protein Name / Synonyms
SARS-CoV-2 N protein, nucleocapsid protein
Expressed Region
Met1 - Ala419
Expression SystemE. coli
TagN-terminal histidine tag
Purity
>95 %
Purity Determined BySDS-PAGE under reducing conditions and visualized by Coomassie blue staining
Molecular Weight (kDa)
∼50 kDa
Format
Liquid
Formulation
15 mM Na2HPO4, 5 mM NaH2PO4, 0.25 M NaCl, pH 7.5
Concentration (lot specific)
Lot specific (see the label on the vial), determined by Bradford protein assay.
Research AreaInfectious Disease, COVID-19
Shipping TypeBlue ice
Storage-20°C
SDS-PAGE Image
SDS-PAGE

Stability & Storage

Storage/Stability
Upon arrival, the protein may be stored for 2 weeks at 4°C. For long term storage, it is recommended to store at -20°C or -80°C in appropriate aliquots. Avoid repeated freeze-thaw cycles.

Related Coronavirus Proteins

Spike Protein, S1 Subunit
230-01101
Spike Protein, S1 Subunit, Host Cell RBD
230-01102
Spike Protein, S2 Subunit
230-01103
S1 Subunit Protein (RBD) with C-terminal Fc tag
230-20405
S1 Subunit Protein (RBD) with C-terminal His-tag
230-20406
S1 Subunit Protein with C-terminal His-tag
230-20407
S2 Subunit Protein with C-terminal His-tag
230-20408
Nucleocapsid Protein with C-terminal His-tag
230-20409

citations

  • An intranasal live-attenuated SARS-CoV-2 vaccine limits virus transmission

    Species:
    Other
    Sample Type:
    Serum (hamster sera)
    Year:
    2024
    Journal Name:
    Nature Communications
    PubMed ID:
    38307868
  • Dysregulated naive B cells and de novo autoreactivity in severe COVID-19

    Year:
    2022
    Journal Name:
    Nature
  • Post-Vaccination Detection of SARS-CoV-2 Antibody Response with Magnetic Nanoparticle-Based Electrochemical Biosensor System

    Year:
    2023
    Journal Name:
    Biosensors-Basel
  • Simultaneous Detection of SARS-CoV-2 Nucleoprotein and Receptor Binding Domain by a Multi-Area Reflectance Spectroscopy Sensor

    Year:
    2023
    Journal Name:
    Biosensors-Basel
  • Extrafollicular B cell responses correlate with neutralizing antibodies and morbidity in COVID-19

    Species:
    Human
    Sample Type:
    Conditioned Media (HEK Expressed, coupling to microspheres)
    Year:
    2020
    Journal Name:
    Nature Immunology
  • Direct activation of the alternative complement pathway by SARS-CoV-2 spike protein is blocked by factor D inhibition.Blood

    Year:
    2020
    PubMed ID:
    32877502
  • Nanoparticle transfer biosensors for the non-invasive detection of SARS-CoV-2 antigens trapped in surgical face masks

    Year:
    2021
    Journal Name:
    Sensors and Actuators B-Chemical
    PubMed ID:
    34188360
  • Antibody Levels Poorly Reflect on the Frequency of Memory B Cells Generated following SARS-CoV-2, Seasonal Influenza, or EBV Infection

    Year:
    2022
    Journal Name:
    Cells
  • Longitudinal Variations in Antibody Responses against SARS-CoV-2 Spike Epitopes upon Serial Vaccinations

    Year:
    2023
    Journal Name:
    International Journal of Molecular Sciences
  • Nucleocapsid protein binding DNA aptamers for detection of SARS-COV-2

    Year:
    2023
    Journal Name:
    Current Research in Biotechnology

Você também pode estar interessado nos seguintes produtos:



Referência
Descrição
Cond.
Price Bef. VAT